Monitor for the actual sale on Form 4 and any subsequent insider selling patterns. The CEO's intent to sell a large block could signal lack of confidence ahead of the next earnings report or material news.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 13 $97.82entry
- T+1 · 6mo ago +0.66%α +0.66% · $98.47
- T+5 · 6mo ago +0.37%α +1.53% · $98.19
- T+20 · 5mo ago +33.81%α +34.42% · $130.90
- T+60 · 3mo ago +72.20%α +68.03% · $168.45
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Co-founder and CEO AmirAli Talasaz filed a Form 144 to sell 260,000 shares of Guardant Health common stock, valued at approximately $26.1 million based on the filing date. This is a material insider sale by the CEO, representing a significant portion of his holdings and signaling potential bearish sentiment ahead of any upcoming catalysts.
Key Facts
- CEO AmirAli Talasaz filed to sell 260,000 shares of GH common stock.
- Estimated sale value: ~$26.1 million based on filing date.
- Shares to be sold through Stifel Nicolaus & Company Inc.
- Sale includes shares acquired via open market purchases, RSUs, stock options, and founder shares.
- Filing date: May 12, 2026; proposed sale date also May 12, 2026.
- Shares held indirectly through Talasaz & Eskandari 2017 Family Trust.
Financial Impact
CEO selling ~$26.1M in stock, representing a material portion of his holdings.
Risk Factors
- CEO selling large stake may indicate negative outlook or upcoming bad news.
- Sale may pressure stock price if executed in open market.
- Potential for additional insider selling if others follow suit.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001972481-26-000154 |
| Document: 0001972481-26-000154-index.html | 0001972481-26-000154 |
| Document: 0001972481-26-000154.txt | 0001972481-26-000154 |
Track record
38 reports on GH
3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 6 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers